These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9059793)

  • 41. Cortical myoclonus in levodopa-responsive parkinsonism.
    Caviness JN; Adler CH; Newman S; Caselli RJ; Muenter MD
    Mov Disord; 1998 May; 13(3):540-4. PubMed ID: 9613750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Upregulation of striatal adenosine A2A receptor mRNA in 6-hydroxydopamine-lesioned rats intermittently treated with L-DOPA.
    Tomiyama M; Kimura T; Maeda T; Tanaka H; Kannari K; Baba M
    Synapse; 2004 Jun; 52(3):218-22. PubMed ID: 15065221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apomorphine-induced penile erections in Parkinson's disease.
    O'Sullivan JD; Hughes AJ
    Mov Disord; 1998 May; 13(3):536-9. PubMed ID: 9613749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transdermal apomorphine permeation from microemulsions: a new treatment in Parkinson's disease.
    Priano L; Albani G; Brioschi A; Calderoni S; Lopiano L; Rizzone M; Cavalli R; Gasco MR; Scaglione F; Fraschini F; Bergamasco B; Mauro A
    Mov Disord; 2004 Aug; 19(8):937-42. PubMed ID: 15300660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Motor response to repeated dopaminergic stimulation in Parkinson's disease.
    Obeso JA; Luquin MR; Grandas F; Vaamonde J; Laguna J; Martinez-Lage JM
    Clin Neuropharmacol; 1992 Feb; 15(1):75-9. PubMed ID: 1349508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dopaminergic modulation of visual-spatial working memory in Parkinson's disease.
    Costa A; Peppe A; Dell'Agnello G; Carlesimo GA; Murri L; Bonuccelli U; Caltagirone C
    Dement Geriatr Cogn Disord; 2003; 15(2):55-66. PubMed ID: 12566593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Somatosensory evoked potentials and dopaminergic responsiveness to apomorphine and levodopa in parkinsonian patients.
    Miranda M; Castillo JL; Araya F
    Behav Neurol; 1996; 9(3):149-53. PubMed ID: 24487514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Apomorphine].
    Esteban Muñoz J
    Neurologia; 1995 Oct; 10(8):330-7. PubMed ID: 8554783
    [No Abstract]   [Full Text] [Related]  

  • 49. [Visual evoked potentials in Parkinson disease].
    Luquin MR; Obeso JA; Artieda J; Lacruz F; Martínez Lage JM
    Arch Neurobiol (Madr); 1986; 49(4):213-9. PubMed ID: 3753145
    [No Abstract]   [Full Text] [Related]  

  • 50. A tale of two patients: Levodopa and creative awakening in parkinson's disease - A qualitative report.
    Chacko J; George S; Cyriac S; Chakrapani B
    Asian J Psychiatr; 2019 Jun; 43():179-181. PubMed ID: 31212166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SEPs N30 amplitude in Parkinson's disease and in pharmacologically induced rigidity: relationship with the clinical status.
    Stanzione P; Traversa R; Pierantozzi M; Semprini R; Loberti M; Peppe A; Santilli AM; Bernardi G
    Eur J Neurol; 1997 Jan; 4(1):24-38. PubMed ID: 24283819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of a female patient with persistent genital arousal and Parkinson's disease with paliperidone.
    Fountoulakis KN; Tegos T; Goulis DG; Nimatoudis I; Kimiskidis V
    Aust N Z J Psychiatry; 2017 Jan; 51(1):98-99. PubMed ID: 27422565
    [No Abstract]   [Full Text] [Related]  

  • 53. Vagus nerve somatosensory evoked potentials in Parkinson's disease.
    Polak T; Weise D; Metzger F; Ehlis AC; Langer JB; Schramm A; Fallgatter AJ; Classen J
    J Neurol; 2011 Dec; 258(12):2276-7. PubMed ID: 21559938
    [No Abstract]   [Full Text] [Related]  

  • 54. N30 in PD.
    Ozaki I; Shimamura H; Baba M; Matsunaga M
    Neurology; 1996 Jul; 47(1):304; author reply 304-6. PubMed ID: 8710109
    [No Abstract]   [Full Text] [Related]  

  • 55. N30 in PD.
    Rossini PM
    Neurology; 1996 Jul; 47(1):303-4; author reply 304-6. PubMed ID: 8710108
    [No Abstract]   [Full Text] [Related]  

  • 56. A new video/computer method to measure the amount of overall movement in experimental animals (two-dimensional object-difference method).
    Hashimoto T; Izawa Y; Yokoyama H; Kato T; Moriizumi T
    J Neurosci Methods; 1999 Sep; 91(1-2):115-22. PubMed ID: 10522830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Motor cortex plasticity and excitability in Parkinson's disease.
    Bareš M; Kaňovský P; Rektor I
    Clin Neurophysiol; 2014 Oct; 125(10):2135-6. PubMed ID: 24631014
    [No Abstract]   [Full Text] [Related]  

  • 58. Reply to "motor cortex plasticity and excitability in Parkinson's disease".
    Filipović SR
    Clin Neurophysiol; 2014 Oct; 125(10):2136-7. PubMed ID: 24618213
    [No Abstract]   [Full Text] [Related]  

  • 59. Brain Networks Involved in Sensory Perception in Parkinson's Disease: A Scoping Review.
    Permezel F; Alty J; Harding IH; Thyagarajan D
    Brain Sci; 2023 Nov; 13(11):. PubMed ID: 38002513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spontaneous sleep modulates the firing pattern of parkinsonian subthalamic nucleus.
    Stefani A; Galati S; Peppe A; Bassi A; Pierantozzi M; Hainsworth AH; Bernardi G; Orlacchio A; Stanzione P; Mazzone P
    Exp Brain Res; 2006 Jan; 168(1-2):277-80. PubMed ID: 16328297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.